Zeke Capital Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.52M | Sell |
2,956
-992
| -25% | -$509K | 0.1% | 98 |
|
|
2022
Q3 | $1.79M | Hold |
3,948
| – | – | 0.13% | 77 |
|
|
2022
Q2 | $1.91M | Sell |
3,948
-1,403
| -26% | -$677K | 0.13% | 79 |
|
|
2022
Q1 | $2.63M | Buy |
5,351
+1,816
| +51% | +$892K | 0.13% | 74 |
|
|
2021
Q4 | $1.64M | Sell |
3,535
-333
| -9% | -$154K | 0.1% | 68 |
|
|
2021
Q3 | $1.44M | Sell |
3,868
-174
| -4% | -$64.9K | 0.08% | 78 |
|
|
2021
Q2 | $1.54M | Buy |
4,042
+4
| +0.1% | +$1.53K | 0.1% | 83 |
|
|
2021
Q1 | $1.45M | Buy |
4,038
+556
| +16% | +$200K | 0.1% | 71 |
|
|
2020
Q4 | $1.12M | Sell |
3,482
-346
| -9% | -$111K | 0.09% | 73 |
|
|
2020
Q3 | $1.03M | Buy |
3,828
+1,492
| +64% | +$401K | 0.12% | 57 |
|
|
2020
Q2 | $614K | Sell |
2,336
-1,931
| -45% | -$508K | 0.12% | 83 |
|
|
2020
Q1 | $969K | Sell |
4,267
-12,505
| -75% | -$2.84M | 0.27% | 51 |
|
|
2019
Q4 | $5.07M | Sell |
16,772
-963
| -5% | -$291K | 0.42% | 44 |
|
|
2019
Q3 | $4.26M | Buy |
17,735
+833
| +5% | +$200K | 0.38% | 54 |
|
|
2019
Q2 | $4.77M | Buy |
16,902
+4,912
| +41% | +$1.39M | 0.45% | 49 |
|
|
2019
Q1 | $3.44M | Buy |
11,990
+1,600
| +15% | +$459K | 0.32% | 69 |
|
|
2018
Q4 | $2.73M | Buy |
10,390
+3,940
| +61% | +$1.03M | 0.26% | 78 |
|
|
2018
Q3 | $1.77M | Hold |
6,450
| – | – | 0.14% | 119 |
|
|
2018
Q2 | $1.54M | Hold |
6,450
| – | – | 0.14% | 120 |
|
|
2018
Q1 | $1.42M | Hold |
6,450
| – | – | 0.13% | 134 |
|
|
2017
Q4 | $1.45M | Buy |
6,450
+2,048
| +47% | +$461K | 0.15% | 123 |
|
|
2017
Q3 | $836K | Buy |
4,402
+2,457
| +126% | +$467K | 0.11% | 143 |
|
|
2017
Q2 | $366K | Buy |
1,945
+218
| +13% | +$41K | 0.07% | 164 |
|
|
2017
Q1 | $286K | Buy |
1,727
+240
| +16% | +$39.7K | 0.06% | 183 |
|
|
2016
Q4 | $214K | Buy |
+1,487
| New | +$214K | 0.06% | 176 |
|